2m 2m 2m 2m 2m 2m 2m
DENALI THERAPTCS (DNLI)
NASDAQ
$18.94+$0.26 (+1.39%)
Price as of Oct 22, 2026 7:30 PM EDT- $3.0BMarket Cap
- 17.12%1-Year Change
- BiotechnologyIndustry
DENALI THERAPTCS (DNLI)
$18.94+$0.26 (+1.39%)
DNLI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.68 | ||
Change | -$0.25 (-1.32%) | ||
Open | $18.93 | ||
High | $19.13 | ||
Low | $18.58 | ||
Previous Close | $18.93 | ||
Volume | 1,429,264 | ||
30-Day Average Volume | 2,003,209 | ||
1-Week Change | 4.53% | ||
1-Month Change | -8.74% | ||
1-Year Change | 17.12% | ||
3-Year Change | 1.97% | ||
5-Year Change | -59.54% | ||
Fundamentals | |||
Shares Outstanding | 159.8M | ||
Total Assets | $1.2B | ||
Market Cap | $3.0B | ||
Enterprise Value | $2.8B | ||
Period: QTR TTM FY | |||
Revenue | $3.6M | ||
Net Income | -$127.6M | ||
Free Cash Flow | -$97.8M | ||
EBIT | -$127.6M | ||
EBITDA | -$124.0M | ||
Net Working Capital | $663.8M | ||
EPS | -$0.68 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | 773 | ||
P/B | 4 | ||
P/E | -27 | ||
PEG | -19 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue